Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america.
The DOI matches its Crossref record; 360 of the 360 references it cites were found in a registry or an index.
Abstract
This document updates and expands the initial Infectious Diseases Society of America (IDSA) Fever and Neutropenia Guideline that was published in 1997 and first updated in 2002. It is intended as a guide for the use of antimicrobial agents in managing patients with cancer who experience chemotherapy-induced fever and neutropenia. Recent advances in antimicrobial drug development and technology, clinical trial results, and extensive clinical experience have informed the approaches and recommendations herein. Because the previous iteration of this guideline in 2002, we have a developed a clearer definition of which populations of patients with cancer may benefit most from antibiotic, antifungal, and antiviral prophylaxis. Furthermore, categorizing neutropenic patients as being at high risk or low risk for infection according to presenting signs and symptoms, underlying cancer, type of therapy, and medical comorbidities has become essential to the treatment algorithm. Risk stratification is a recommended starting point for managing patients with fever and neutropenia. In addition, earlier detection of invasive fungal infections has led to debate regarding optimal use of empirical or preemptive antifungal therapy, although algorithms are still evolving. What has not changed is the indication for immediate empirical antibiotic therapy. It remains true that all patients who present with fever and neutropenia should be treated swiftly and broadly with antibiotics to treat both gram-positive and gram-negative pathogens. Finally, we note that all Panel members are from institutions in the United States or Canada; thus, these guidelines were developed in the context of North American practices. Some recommendations may not be as applicable outside of North America, in areas where differences in available antibiotics, in the predominant pathogens, and/or in health care–associated economic conditions exist. Regardless of venue, clinical vigilance and immediate treatment are the universal keys to managing neutropenic patients with fever and/or infection.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Other studies, however, did not observe an association between antimicrobial timing and mortality (112-117).”
From Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. (2021) · cites this paper as [113]
In the citing paper
“patients with febrile neutropenia who fail to defervesce after 4–7 days of broad-spectrum antibacterial therapy are at increased risk of having fungal disease (Table 2) [175, 176].”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [175]
Citations
Cites
Items 201–360 of 360
Masaoka, T. (2004) · Clinical Infectious Diseases · doi:10.1086/383054 · Cited by 130
Vardakas, K. Z., Michalopoulos, A., & Falagas, M. E. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05727.x · Cited by 129
Kanda, Y., Yamamoto, R., Chizuka, A., Hamaki, T., Suguro, M., Arai, C., Matsuyama, T., Takezako, N., Miwa, A., Kern, W., et al. (2000) · Cancer · doi:10.1002/1097-0142(20001001)89:7<1611::aid-cncr27>3.0.co;2-b · Cited by 128
New antimicrobial agents for the treatment of Gram-positive bacterial infections
Aksoy, D. Y., & Ünal, S. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01933.x · Cited by 124
Johnson, D. C., Johnson, F. L., & Goldman, S. (1994) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199410000-00015 · Cited by 122
Seifert, H., Cornely, O. A., Seggewiss, K., Decker, M., Stefanik, D., Wisplinghoff, H., & Fätkenheuer, G. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.1.118-123.2003 · Cited by 122
Hebart, H. F., Klingspor, L., Klingebiel, T. E., Loeffler, J., Tollemar, J. G., Ljungman, P. T., Wandt, H., Schaefer‐Eckart, K., Dornbusch, H. J., Meisner, C., et al. (2008) · Bone Marrow Transplantation · doi:10.1038/bmt.2008.355 · Cited by 119
Feld, R. D., dePauw, B. E., Berman, S., Keating, A., & Ho, W. G. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.21.3690 · Cited by 118
New Trends in Patient Management: Risk-Based Therapy for Febrile Patients with Neutropenia
Rolston, K. V. I. (1999) · Clinical Infectious Diseases · doi:10.1086/598624 · Cited by 118
Self-citationPortugal, R. D., Garnica, M., & Nucci, M. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.0856 · Cited by 117
Cordonnier, C., Maury, S., Pautas, C., Bastié, J. N., Chehata, S., Castaigné, S., Kuentz, M., Bretagne, S., & Ribaud, P. (2004) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1704469 · Cited by 116
Rapid diagnosis of invasive aspergillosis by antigen detection
Wheat, L. J. (2003) · Transplant Infectious Disease · doi:10.1111/j.1399-3062.2003.00031.x · Cited by 116
Paul, M., Grozinsky-Glasberg, S., Soares-Weiser, K., & Leibovici, L. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003344.pub2 · Cited by 115
Influenza Immunization of Adult Patients with Malignant Diseases
ORTBALS, D. W., LIEBHABER, H., PRESANT, C. A., VAN AMBURG, A. L., & LEE, J. Y. (1977) · Annals of Internal Medicine · doi:10.7326/0003-4819-87-5-552 · Cited by 114
Meunier, F., Zinner, S. H., Gaya, H., Calandra, T., Viscoli, C., Klastersky, J., & Glauser, M. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.5.873 · Cited by 112
Treatment of Hickman Catheter Sepsis Using Antibiotic Lock Technique
Krzywda, E. A., Andris, D. A., Edmiston, C. E., & Quebbeman, E. J. (1995) · Infection Control & Hospital Epidemiology · doi:10.1086/647015 · Cited by 111
Hidalgo, M. M., Hornedo, J., Lumbreras, C., et al. (1999) · PubMed · Cited by 110
Respiratory syncytial virus infection following hematopoietic stem cell transplantation
Small, T., Casson, A., Malak, S., Boulad, F., Kiehn, T. E., Stiles, J., Ushay, H. M., & Sepkowitz, K. A. (2002) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1703365 · Cited by 109
Self-citationGil, L., Styczyński, J., & Komarnicki, M. A. (2007) · Infection · doi:10.1007/s15010-007-6350-2 · Cited by 109
Paul, M., Borok, S., Fraser, A., Vidal, L., & Leibovici, L. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki028 · Cited by 108
Nordøy, T., Aaberge, I. S., Husebekk, A., Samdal, H. H., Steinert, S., Melby, H., & Kolstad, A. (2002) · Medical Oncology · doi:10.1385/mo:19:2:71 · Cited by 107
Therapeutic Drug Monitoring of Posaconazole: a Monocentric Study with 54 Adults
Lebeaux, D., Lanternier, F., Elie, C., Suarez, F., Buzyn, A., Viard, J.-P., Bougnoux, M.-E., Lecuit, M., Jullien, V., & Lortholary, O. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00939-09 · Cited by 105
Noel, G. J., Bradley, J. S., Kauffman, R. E., et al. (2007) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e3180cbd382 · Cited by 104
Utility of Influenza Vaccination for Oncology Patients
Pollyea, D. A., Brown, J. M. Y., & Horning, S. J. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.6908 · Cited by 104
Vehreschild, J. J., Böhme, A., Buchheidt, D., Arenz, D., Harnischmacher, U., Heußel, C. P., Ullmann, A. J., Mousset, S., Hummel, M., Frommolt, P., et al. (2007) · Journal of Infection · doi:10.1016/j.jinf.2007.07.003 · Cited by 104
Bow, E. J., Loewen, R., Cheang, M., et al. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.6.2254 · Cited by 103
Self-citationRAAD, I. I., Buzaid, A. C., Rhyne, J. A., Hachem, R. Y., Darouiche, R. O., Safar, H., Albitar, M. X., & Sherertz, R. J. (1997) · Clinical Infectious Diseases · doi:10.1086/514518 · Cited by 102
Self-citationEarly Discharge of Low‐Risk Febrile Neutropenic Children and Adolescents with Cancer
Aquino, V. M., Tkaczewski, I., & Buchanan, G. R. (1997) · Clinical Infectious Diseases · doi:10.1086/514512 · Cited by 100
van de Wetering, M. D., de Witte, M. A., Kremer, L. C. M., Offringa, M., Scholten, R. J. P. M., & Caron, H. N. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.03.006 · Cited by 100
Limaye, A. P., Huang, M.-L. W., Leisenring, W. M., et al. (2001) · The Journal of Infectious Diseases · doi:10.1086/318089 · Cited by 100
Control of Influenza A on a Bone Marrow Transplant Unit
Weinstock, D. M., Eagan, J., Malak, S. A., Rogers, M., Wallace, H., Kiehn, T. E., & Sepkowitz, K. A. (2000) · Infection Control & Hospital Epidemiology · doi:10.1086/501726 · Cited by 99
Self-citationRespiratory Virus Infections in Adults with Hematologic Malignancies: A Prospective Study
Martino, R., Rámila, E., Rabella, N., et al. (2003) · Clinical Infectious Diseases · doi:10.1086/344899 · Cited by 99
de Fontbrune, F. S., Robin, M., Porcher, R., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/521912 · Cited by 99
Shenep, J. L., Flynn, P. M., Baker, D. K., Hetherington, S., Hudson, M. M., Hughes, W. T., Patrick, C. C., Roberson, P. K., Sandlund, J. T., Santana, V. M., et al. (2001) · Clinical Infectious Diseases · doi:10.1086/317552 · Cited by 98
Ghanem, G., Boktour, M. R., Warneke, C. L., Pham-Williams, T., Kassis, C., Bahna, P., Aboufaycal, H., Hachem, R. Y., & RAAD, I. I. (2007) · Medicine · doi:10.1097/md.0b013e318030d344 · Cited by 97
Self-citationDiagnosis of Venous Access Port--Related Infections
Douard, M. C., Arlet, G., Longuet, P., Troje, C., Rouveau, M., Ponscarme, D., & Eurin, B. (1999) · Clinical Infectious Diseases · doi:10.1086/313444 · Cited by 97
Vellenga, E., Groot, C. A. U.-D., de Wit, R., Keizer, H. J., Löwenberg, B., ten Haaft, M. A., Tj, D. W., Verhagen, C. A. H. H. V. M., Stoter, G., Rutten, F., et al. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.2.619 · Cited by 97
Weisser, M., Rausch, C., Droll, A., Simcock, M., Sendi, P., Steffen, I., Buitrago, C., Sonnet, S., Gratwohl, A., Passweg, J., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/444462 · Cited by 94
Hidalgo, M., Hornedo, J., Lumbreras, C., Trigo, J. M., Colomer, R., Perea, S., G�mez, C., Ruiz, A., Garc�a-Carbonero, R., & Cort�s-Funes, H. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19990101)85:1<213::aid-cncr29>3.0.co;2-d · Cited by 94
Flynn, P. M., Shenep, J. L., & Barrett, F. F. (1988) · Journal of Clinical Microbiology · doi:10.1128/jcm.26.5.1045-1046.1988 · Cited by 92
Posaconazole Therapeutic Drug Monitoring: a Reference Laboratory Experience
Thompson, G. R., Rinaldi, M. G., Pennick, G., Dorsey, S. A., Patterson, T. F., & Lewis, J. S. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00240-09 · Cited by 91
Wingard, J. R., Carter, S. L., Walsh, T. J., Kurtzberg, J., Small, T. N., Gersten, I. D., Mendizabal, A. M., Leather, H., Confer, D. L., Baden, L. R., et al. (2007) · Blood · doi:10.1182/blood.v110.11.163.163 · Cited by 91
Self-citationCruciani, M., Malena, M., Bosco, O., Nardi, S., Serpelloni, G., & Mengoli, C. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.01.234 · Cited by 91
-Lactam-Resistant Enterobacter Bacteremia in Febrile Neutropenic Patients Receiving Monotherapy
Johnson, M. P., & Ramphal, R. (1990) · The Journal of Infectious Diseases · doi:10.1093/infdis/162.4.981 · Cited by 89
Corapcioglu, F. V., Sarper, N., & Zengin, E. (2006) · Pediatric Hematology and Oncology · doi:10.1080/08880010500506370 · Cited by 89
Home treatment of febrile neutropenia: An empirical oral antibiotic regimen
Gardembas-Pain, M., Desablens, B., Sensebé, L., Lamy, T., Ghandour, C., & Boasson, M. (1991) · Annals of Oncology · doi:10.1093/oxfordjournals.annonc.a057996 · Cited by 88
Prospective Study of Bacteremia and Complications With EUS FNA of Rectal and Perirectal Lesions
Levy, M. J., Norton, I. D., Clain, J. E., et al. (2007) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2007.02.029 · Cited by 88
Risk Assessment and Treatment of Low-Risk Patients with Febrile Neutropenia
Kern, W. V. (2006) · Clinical Infectious Diseases · doi:10.1086/499352 · Cited by 87
Timmer-Bonte, J. N. H., Adang, E., Smit, H. J. M., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.3281 · Cited by 85
Rubinstein, E., Lode, H., Grassi, C., & Antibiotic Study Group (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/20.5.1217 · Cited by 84
Oral administration of cefixime to lower risk febrile neutropenic children with cancer
Paganini, H. R., Sarkis, C. M., De Martino, M. G., Zubizarreta, P. A., Casimir, L., Fernandez, C., Armada, A. A., Rodriguez-Brieshcke, M. T., & Debbag, R. (2000) · Cancer · doi:10.1002/1097-0142(20000615)88:12<2848::aid-cncr27>3.0.co;2-2 · Cited by 84
Vu, D., Peck, A. J., Nichols, W. G., Varley, C., Englund, J. A., Corey, L., & Boeckh, M. (2007) · Clinical Infectious Diseases · doi:10.1086/518985 · Cited by 83
Self-citationRAAD, I. I., Escalante, C. P., Hachem, R. Y., Hanna, H. A., Husni, R., Afif, C., Boktour, M. R., Whimbey, E. E., Kontoyiannis, D. P., Jacobson, K. L., et al. (2003) · Cancer · doi:10.1002/cncr.11613 · Cited by 82
Self-citationZuckermann, J., Moreira, L. B., Stoll, P., Moreira, L. M., Kuchenbecker, R. S., & Polanczyk, C. A. (2007) · Annals of Hematology · doi:10.1007/s00277-007-0390-7 · Cited by 80
Glasmacher, A. G., Lilienfeld‐Toal, M. V., Schulte, S., Hahn, C., Schmidt‐Wolf, I. G. H., & Prentice, A. (2005) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2005.01239.x · Cited by 78
Biron, P., Fuhrmann, C., Curé, H., Viens, P., Lefebvre, D., Thyss, A., Viot, M., Soler-Michel, P., Rollin, C., & Gres, J. J. (1998) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/42.4.511 · Cited by 76
Ullery, B. W., Pieracci, F. M., Rodney, J. R. M., & Barie, P. S. (2009) · Surgical Infections · doi:10.1089/sur.2008.061 · Cited by 76
Treatment of Hickman Catheter Sepsis Using Antibiotic Lock Technique
Krzywda, E. A., Andris, D. A., Edmiston, C. E., et al. (1995) · Infection Control and Hospital Epidemiology · doi:10.2307/30141101 · Cited by 75
Yamamura, D. L. R., Gucalp, R. A., Carlisle, P. S., Cimino, M. A., Roberts, J. G., & Rotstein, C. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.8.1704 · Cited by 74
Playford, E. G., Webster, A. C., Sorrell, T. C., & Craig, J. C. (2006) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-006-0182-3 · Cited by 73
Randomized trial of beta-lactam regimens in febrile neutropenic cancer patients
Anaissie, E. J., Fainstein, V., Bodey, G. P., Rolston, K. V. I., Elting, L. S., Kantarjian, H. M., Cabanillas, F., & McCredie, K. B. (1988) · The American Journal of Medicine · doi:10.1016/0002-9343(88)90140-4 · Cited by 71
Self-citationRamphal, R., Gucalp, R. A., Rotstein, C., et al. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(96)00113-1 · Cited by 71
María Elena Santolaya de, P., Ricardo Rabagliati, B., Teresa Bidart, H., Ernesto Payá, G., D, A. M. G., Ricardo Morales, I., Stephanie Braun, J., Bronfman, L., Marcela Ferrés, G., Claudio Flores, P., et al. (2005) · Revista chilena de infectología · doi:10.4067/s0716-10182005000500001 · Cited by 70
Gómez, L., Garau, J., Estrada, C. M., et al. (2003) · Cancer · doi:10.1002/cncr.11044 · Cited by 69
Trifilio, S. M., Verma, A., & Mehta, J. (2004) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1704423 · Cited by 69
Cherif, H., Björkholm, M., Engervall, P., Johansson, P., Ljungman, P. T., Hast, R., & Kalin, M. (2004) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540410017590 · Cited by 69
RICHARD, D. A., Nousia‐Arvanitakis, S., Sollich, V., et al. (1997) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199706000-00007 · Cited by 67
Antifungal agents – clinical pharmacokinetics and drug interactions
Lipp, H. (2008) · Mycoses · doi:10.1111/j.1439-0507.2008.01523.x · Cited by 66
Gaur, A. H., Flynn, P. M., Heine, D. J., Giannini, M. A., Shenep, J. L., & Hayden, R. T. (2005) · Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000160950.83583.7f · Cited by 64
Persson, L. A., Söderquist, B., Engervall, P., Vikerfors, T., Hansson, L., & Tidefelt, U. (2005) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2004.00387.x · Cited by 64
Böhme, A., Shah, P. M., Stille, W., & Hoelzer, D. T. (1998) · PubMed · Cited by 62
Kaye, K. S., Kanafani, Z. A., Dodds, A. E., Engemann, J. J., Weber, S. G., & Carmeli, Y. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00060-06 · Cited by 62
Negative catheter-tip culture and diagnosis of catheter-related bacteremia.
Douard, M. C., Clementi, E., Arlet, G., et al. (1995) · PubMed · Cited by 62
Mustafa, M. M., Carlson, L., Tkaczewski, I., et al. (2001) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200103000-00036 · Cited by 61
Beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for treating sepsis
Paul, M., Leibovici, L., Grozinsky, S., Silbiger, I., & Soares-Weiser, K. (2001) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003344 · Cited by 60
Streptococcus pneumoniae Bacteremia in Patients With Cancer
Kumashi, P., Girgawy, E., Tarrand, J. J., et al. (2005) · Medicine · doi:10.1097/01.md.0000180045.26909.29 · Cited by 60
Paul, M., Schlesinger, A., Grozinsky‐Glasberg, S., Soares‐Weiser, K., & Leibovici, L. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003038 · Cited by 60
Burack, R. C., Gimotty, P. A., George, J., McBride, S., Moncrease, A., Simon, M. S., Dews, P., & Coombs, J. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980615)82:12<2391::aid-cncr13>3.0.co;2-k · Cited by 59
Hodgson‐Viden, H., Grundy, P. E., & Robinson, J. L. (2005) · BMC Pediatrics · doi:10.1186/1471-2431-5-10 · Cited by 57
Chatzinikolaou, I., Hanna, H. A., Hachem, R. Y., Alakech, B., Tarrand, J. J., & RAAD, I. I. (2004) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2004.07.007 · Cited by 56
Self-citationProphylactic Antimicrobial Agents and the Importance of Fitness
Baden, L. R. (2005) · New England Journal of Medicine · doi:10.1056/nejme058133 · Cited by 56
Escalante, C. P., Weiser, M. A., Manzullo, E. F., Benjamin, R. S., Rivera, E., Lam, T. P., Ho, V., Valdres, R. U., Lee, E. L., Badrina, N., et al. (2003) · Supportive Care in Cancer · doi:10.1007/s00520-004-0613-6 · Cited by 56
Self-citationCy, C., Tang, J., Hsueh, P., et al. (2004) · PubMed · Cited by 56
Kamana, M., Escalante, C. P., Mullen, C. A., Frisbee‐Hume, S. E., & Rolston, K. V. I. (2005) · Cancer · doi:10.1002/cncr.21144 · Cited by 55
Self-citationBehre, G., Link, H., Maschmeyer, G., Meyer, P., Paaz, U., Wilhelm, M., & Hiddemann, W. (1998) · Annals of Hematology · doi:10.1007/s002770050366 · Cited by 54
Chemaly, R. F., Torres, H. A., Aguilera, E. A., Mattiuzzi, G., Cabanillas, M., Kantarjian, H., Gonzalez, V., Safdar, A., & Raad, I. I. (2007) · Clinical Infectious Diseases · doi:10.1086/512374 · Cited by 54
Self-citationβ-Lactam regimens for the febrile neutropenic patient
Bodey, G. P., Fainstein, V., Elting, L. S., Anaissie, E. J., Rolston, K. V. I., Khardori, N. M., Kantarjian, H. M., Plager, C., Murphy, W. K., Holmes, F. A., et al. (1990) · Cancer · doi:10.1002/1097-0142(19900101)65:1<9::aid-cncr2820650105>3.0.co;2-c · Cited by 54
Self-citationJones, G. R., Konsler, G. K., Dunaway, R. P., Gold, S., Cooper, H., & Wells, R. J. (1994) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)81358-7 · Cited by 53
Fever of Unknown Origin in Febrile Leukopenia
Antoniadou, A., & Giamarellou, H. (2007) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2007.08.008 · Cited by 53
Morris, P. G., Hassan, T. M., McNamara, M. G., et al. (2008) · Supportive Care in Cancer · doi:10.1007/s00520-007-0398-5 · Cited by 51
Chemaly, R. F., Hanmod, S. S., Jiang, Y., Rathod, D. B., Mulanovich, V. E., Adachi, J. A., Rolston, K. V. I., RAAD, I. I., & Hachem, R. Y. (2009) · Medicine · doi:10.1097/md.0b013e3181af01fc · Cited by 48
Self-citationWingard, J. R., & Elmongy, M. B. (2009) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2009.01.003 · Cited by 48
Self-citationFritsche, T. R., Sader, H. S., & Jones, R. N. (2003) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(03)00114-7 · Cited by 48
Gill, S. I., Carney, D. A., Ritchie, D., et al. (2009) · Annals of Oncology · doi:10.1093/annonc/mdp297 · Cited by 48
Winston, D. J., Lazarus, H. M., Beveridge, R. A., Hathorn, J. W., Gucalp, R., Ramphal, R., Chow, A. W., Ho, W. G., Horn, R., Feld, R., et al. (2001) · Clinical Infectious Diseases · doi:10.1086/318500 · Cited by 47
Bruckner, L. B., & Gigliotti, F. (2006) · Seminars in Pediatric Infectious Diseases · doi:10.1053/j.spid.2006.06.008 · Cited by 47
Johnson, P. R. E., Yin, J. A. L., & Tooth, J. A. (1992) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/30.2.203 · Cited by 46
Aubron, C., Poirel, L., Fortineau, N., et al. (2005) · Microbial Drug Resistance · doi:10.1089/mdr.2005.11.254 · Cited by 46
Lehrnbecher, T., Stanescu, A., & Kühl, J. (2002) · Infection · doi:10.1007/s15010-002-2094-1 · Cited by 46
Wang, F., Liu, C.-Y., Hsu, H., Gau, J., Chau, W., Haung, M.-L., & Ho, C. (1999) · Chemotherapy · doi:10.1159/000007228 · Cited by 44
Meropenem versus ceftazidime as empirical monotherapy for febrile neutropenic cancer patients
Vandercam, B., Gérain, J., Humblet, Y., Ferrant, A., Wauters, G., Moreau, M., Longueville, J., Symann, M., & Straetmans, N. (2000) · Annals of Hematology · doi:10.1007/s002770050571 · Cited by 44
Management of the febrile neutropenic cancer patient: lessons from 40 years of study
Bow, E. J. (2005) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2005.01240.x · Cited by 44
Self-citationFreifeld, A. G., Sankaranarayanan, J., Ullrich, F. A., & Sun, J. (2007) · Supportive Care in Cancer · doi:10.1007/s00520-007-0308-x · Cited by 44
Self-citationThe Value of Skin Biopsies in Febrile, Neutropenic, Immunocompromised Children
Allen, U., Smith, C. B., & Prober, C. G. (1986) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.1986.02140190069028 · Cited by 43
PERIPHERAL VS. CENTRAL BLOOD CULTURES IN PATIENTS ADMITTED TO A PEDIATRIC ONCOLOGY WARD
Adamkiewicz, T. V., Lorenzana, A., Doyle, J., & RICHARDSON, S. (1999) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199906000-00018 · Cited by 43
Is Monotherapy for Febrile Neutropenia Still a Viable Alternative?
Ramphal, R. (1999) · Clinical Infectious Diseases · doi:10.1086/598623 · Cited by 43
Impaired gut function as risk factor for invasive candidiasis in neutropenic patients
Blijlevens, N. M. A., Donnelly, J. P., & De Pauw, B. E. (2002) · British Journal of Haematology · doi:10.1046/j.1365-2141.2002.03394.x · Cited by 41
Ragnar Lindblad, S. R. (1998) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365549850160864 · Cited by 41
Falcone, M., Micozzi, A., Pompeo, M. E., Baiocchi, P., Fabi, F., Penni, A., Martino, P., & Venditti, M. (2004) · Journal of Chemotherapy · doi:10.1179/joc.2004.16.6.540 · Cited by 41
Rolston, K. V. I., Manzullo, E. F., Elting, L. S., Frisbee‐Hume, S. E., McMahon, L. W., Theriault, R. L., PATEL, S. R., & Benjamin, R. S. (2006) · Cancer · doi:10.1002/cncr.21908 · Cited by 41
Self-citationMarked intra- and inter-patient variability of itraconazole steady state plasma concentrations.
Poirier, J., Berlioz, F., Isnard, F., & CHEYMOL, G. (1996) · PubMed · Cited by 40
Martino, R., Subirá, M., Altés, A., et al. (1998) · Acta Haematologica · doi:10.1159/000040840 · Cited by 39
Vancomycin-resistant enterococcal infections in bone marrow transplant recipients
Koç, Y., Snydman, D. R., Schenkein, D. S., et al. (1998) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1701303 · Cited by 39
Akova, M., Akan, H., Korten, V., Biberoğlu, K., Hayran, M., Ünal, S., Kars, A., & Kansu, E. (1999) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(99)00096-5 · Cited by 38
Cunha, B. A. (2006) · Medical Clinics of North America · doi:10.1016/j.mcna.2006.07.007 · Cited by 38
Velasco, E. D., da Costa, M. A. D. L., Martins, C. A. S., et al. (1995) · American Journal of Clinical Oncology · doi:10.1097/00000421-199510000-00014 · Cited by 34
Cornely, O. A., Wicke, T., Seifert, H., Bethe, U., Schwonzen, M., Reichert, D. A., Ullmann, A. J., Karthaus, M., Breuer, K., Salzberger, B., et al. (2004) · International Journal of Hematology · doi:10.1007/bf02983537 · Cited by 34
The treatment of febrile neutropenia: from the Dark Ages to the present
Bodey, G. P. (1997) · Supportive Care in Cancer · doi:10.1007/s005200050091 · Cited by 32
Molina, J., Sánchez‐García, J., Torres, A., Alvarez, M. A., Serrano, J., Casaño, J., Gómez, P., Martínez, F., Rodríguez, A., & Martín, C. (2007) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2006.09.007 · Cited by 32
Nucci, M., Landau, M., Silveira, F., Spector, N., & Pulcheri, W. (2001) · Infection Control and Hospital Epidemiology · doi:10.1086/501839 · Cited by 32
Mantadakis, E., Amoiridis, G., Kondi, A., et al. (2007) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0b013e318030d289 · Cited by 32
Oğuz, A., Karadeniz, C., Çıtak, E. Ç., Cil, V., & Eldeş, N. (2006) · Pediatric Hematology and Oncology · doi:10.1080/08880010500506867 · Cited by 31
Palmari, J. P., Teysseire, N., Dussert, C., et al. (1996) · PubMed · Cited by 30
Antibacterial Prophylaxis in Patients with Cancer and Neutropenia
Freifeld, A. G., Sepkowitz, K. A., Martino, P., Steven, N., Billingham, L., Cullen, M. H., & Baden, L. R. (2006) · New England Journal of Medicine · doi:10.1056/nejmc052613 · Cited by 29
Self-citationCloutier, R. L. (2009) · Emergency Medicine Clinics of North America · doi:10.1016/j.emc.2009.04.002 · Cited by 29
Spanik, S., Novotný, J., Mateicka, F., et al. (1999) · Journal of Infection and Chemotherapy · doi:10.1007/s101560050031 · Cited by 28
High dose intravenous ciprofloxacin in febrile neutropenic patients
Johnson, P. R. E., Yin, J. A. L., & Tooth, J. A. (1990) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/26.suppl_f.101 · Cited by 27
Empirical antifungal therapy in selected patients with persistent febrile neutropenia
Aguilar‐Guisado, M., Espigado, I., Cordero, E., Noguer, M., Parody, R., Pachón, J., & Cisneros, J. M. (2009) · Bone Marrow Transplantation · doi:10.1038/bmt.2009.125 · Cited by 27
Horowitz, H. W., Holmgren, D., & Seiter, K. P. (1996) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428199609054816 · Cited by 27
von Lilienfeld‐Toal, M., Schneider, A., Orlopp, K. S., Hahn‐Ast, C., Glasmacher, A. G., & Stüber, F. (2006) · Supportive Care in Cancer · doi:10.1007/s00520-006-0081-2 · Cited by 26
Imaging of the gastrointestinal complications of systemic chemotherapy
Cronin, C. G., O’Connor, M., Lohan, D. G., et al. (2009) · Clinical Radiology · doi:10.1016/j.crad.2009.02.016 · Cited by 26
Grazziutti, M., Dong, L., Miceli, M. H., Cottler‐Fox, M., Krishna, S. G., Fassas, A., van Rhee, F., Barlogie, B., & Anaissie, E. J. (2006) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1705251 · Cited by 26
Timmer-Bonte, J. N. H., Adang, E., Termeer, E. H., Severens, J. L., & Tjan‐Heijnen, V. C. G. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.0898 · Cited by 26
Burgess, D. S., Hall, R. G., & Hardin, T. C. (2003) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(03)00036-1 · Cited by 25
Granulocyte colony-stimulating factors: finding the right indication
Lyman, G. H., & Shayne, M. (2007) · Current Opinion in Oncology · doi:10.1097/cco.0b013e3281a3c0ba · Cited by 25
Gruson, D., Hilbert, G., Pigneux, A., et al. (1998) · PubMed · Cited by 25
RAAD, I. I., Abi-Said, D., Rolston, K. V. I., Karl, C. L., & Bodey, G. P. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980615)82:12<2449::aid-cncr20>3.0.co;2-o · Cited by 25
Self-citationÖzyılkan, Ö., Arslan, Ü. Y., & Baskan, S. (1999) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.1999.14.2.15 · Cited by 23
Vancomycin does not benefit persistently febrile neutropenic people with cancer
Wade, J. C., & Glasmacher, A. G. (2004) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2003.11.008 · Cited by 23
Cefepime Therapy and All‐Cause Mortality
Nguyen, T. D., Williams, B., & Trang, E. (2009) · Clinical Infectious Diseases · doi:10.1086/597264 · Cited by 23
[Consensus: Rational approach towards the patient with cancer, fever and neutropenia].
Santolaya, M. E., Ricardo Rabagliati, B., Bidart, T., et al. (2005) · PubMed · Cited by 23
Marra, C. A., Frighetto, L., Quaia, C. B., et al. (2000) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.20.11.931.35258 · Cited by 22
Adams, J. R., Angelotta, C., & Bennett, C. L. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.05.6812 · Cited by 20
Verma, N., Clarke, R. W., Bolton‐Maggs, P. H. B., et al. (2007) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0b013e3180f61b81 · Cited by 19
Linezolid-Related Pancytopenia in Organ-Transplant Patients: Report of Two Cases
Faguer, S., Kamar, N., Fillola, G., et al. (2007) · Infection · doi:10.1007/s15010-007-6197-6 · Cited by 18
Itraconazole‐enhanced vindesine neurotoxicity in adult acute lymphoblastic leukaemia
Chen, S., Wu, D., Sun, A., Qiu, H., Jin, Z., Tang, X., Miao, M., Fu, Z., Ma, X., Han, Y., et al. (2007) · American Journal of Hematology · doi:10.1002/ajh.20918 · Cited by 16
Engervall, P., Kalin, M., Dornbusch, K., & Björkholm, M. (1999) · Journal of Chemotherapy · doi:10.1179/joc.1999.11.4.278 · Cited by 15
Pauw, B. E. D., & Rubin, R. H. (2006) · Transplant Infectious Disease · doi:10.1111/j.1399-3062.2006.00123.x · Cited by 15
Pauw, B. E. D., & Donnelly, J. P. (2009) · Clinical Infectious Diseases · doi:10.1086/597396 · Cited by 15
Carbapenem resistance in Canada
Toye, B., Krajden, S., Fuksa, M., et al. (2009) · Canadian Medical Association Journal · doi:10.1503/cmaj.090167 · Cited by 14
Efficacy and safety of cefepime
Towne, T. G., Lewis, J. S., & Echevarria, K. L. (2008) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(08)70288-3 · Cited by 14
Approach to the Patient with Prolonged Granulocytopenia
Pizzo, P. A. (1993) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-642-84899-5_5 · Cited by 11
Empirical versus Preemptive Antifungal Therapy for Fever during Neutropenia
Marr, K. A., Leisenring, W. M., & Bow, E. J. (2009) · Clinical Infectious Diseases · doi:10.1086/605601 · Cited by 11
Self-citationGarrison, M. W. (2005) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2005.08.010 · Cited by 9
Emergence of linezolid-resistant enterococci in a neutropenic patient
Mehta, S. J., Johnson, J. K., Venezia, R. A., et al. (2005) · Journal of Hospital Infection · doi:10.1016/j.jhin.2005.05.008 · Cited by 7
Nguyen, T. D., Williams, B., & Ocampo, N. (2009) · Clinical Infectious Diseases · doi:10.1086/603588 · Cited by 6
Prophylactic application of fluoroquinolones for selective decontamination of the gut: friend or foe
van Belkum, A., & Vos, M. D. (2005) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-005-1282-1 · Cited by 5
Mortality Associated with Cefepime Therapy among Neutropenic Patients
Gómez, L., Quintana, S., & Garau, J. (2009) · Clinical Infectious Diseases · doi:10.1086/605535 · Cited by 4
[Clostridium difficile associated diarrhoea--problem of oncological patient?].
Ligová, A., Matuška, M., Mrázková, P., et al. (2009) · PubMed · Cited by 2
Research works printed but not linked: 7
- Owens, 2000, Reduction in vancomycin consumption in patients with fever and neutropenia, Clin Infect Dis, 31, 291
- Rotstein, 1997, Fluoroquinolone prophylaxis for profoundly neutropenic cancer patients: a meta-analysis, Opin Oncol, 4, 2
- Pasqualotto, 2006, Antibacterial prophylaxis in patients with cancer and neutropenia, N Engl J Med, 354, 90, 10.1056/NEJMc052613 · DOI
- Ito, 2006, Antibacterial prophylaxis in patients with cancer and neutropenia, N Engl J Med, 354, 90, 10.1056/NEJMc052613 · DOI
- Greene, 2007, Imaging findings in acute invasive pulmonary aspergillosis: clinical significance of the halo sign, Clin Infect Dis, 44, 373, 10.1086/509917 · DOI · Paper page
- Marks, 2009, Voriconazole (VOR) vs itraconazole (ITR) for primary prophylaxis of invasive fungal infection (IFI) in allogeneic hematopoietic cell transplant (HCT) recipients [abstract M-1249a]
- National Cancer Center Network (NCCN), 2009, Myeloid growth factors: NCCN practice guidelines
Cited by
Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016.
Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J. E., Sprung, C. L., Nunnally, M. E., et al. (2017) · Intensive Care Medicine · doi:10.1007/s00134-017-4683-6 · Cited by 6,621
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Intensive Care Medicine · doi:10.1007/s00134-021-06506-y · Cited by 5,082
Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016.
Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J. E., Sprung, C. L., Nunnally, M. E., et al. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002255 · Cited by 3,652
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021.
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000005337 · Cited by 2,935
Patterson, T. F., Thompson, G. R., Denning, D. W., Fishman, J. A., Hadley, S., Herbrecht, R., Kontoyiannis, D. P., Marr, K. A., Morrison, V. A., Nguyen, M. H., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw326 · Cited by 2,926
Self-citation
Metadata
- Authors
- Freifeld, A. G., Bow, E. J., Sepkowitz, K. A., Boeckh, M. J., Ito, J. I., Mullen, C. A., Raad, I. I., Rolston, K. V., Young, J.-A. H., & Wingard, J. R.
- Affiliations
- University of Nebraska Medical Center (US)
- CancerCare Manitoba (CA)
- Memorial Sloan Kettering Cancer Center (US)
- Fred Hutch Cancer Center (US)
- City Of Hope National Medical Center (US)
- University of Rochester Medicine (US)
- The University of Texas MD Anderson Cancer Center (US)
- University of Minnesota (US)
- University of Florida (US)
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-02-15
- Volume
- 52
- Issue
- 4
- Pages
- e56-e93
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2123859227
- Semantic Scholar
- 61f444a63e765b8981339be50b8136ae0b15cb08
- Cited by
- 3,463
- References
- 360
- Citations by year
- 2026: 176 · 2025: 180 · 2024: 163 · 2023: 211 · 2022: 233 · 2021: 245 · 2020: 260 · 2019: 277 · 2018: 254 · 2017: 267 · 2016: 218 · 2015: 247 · 2014: 248 · 2013: 221 · 2012: 174
- FWCI
- 112.27
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Neutropenia and Cancer Infections
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Keywords
- febrile neutropenia, cancer, chemotherapy-induced neutropenia, antibiotic prophylaxis, antifungal prophylaxis, antiviral prophylaxis, risk stratification, invasive fungal infections, preemptive antifungal therapy, empirical antibiotic therapy, infection management
- MeSH terms
- Anti-Infective Agents, Antineoplastic Agents, Canada, Communicable Diseases, Fever of Unknown Origin, Humans, Neoplasms, Neutropenia, United States
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.